Consolidated Portfolio Review Corp’s Innovator US Equity Buffer ETF March BMAR Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio BMAR Stock Details BMAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,918	Closed	-$1.13M	–	81
2025 Q3	$1.13M	Sell	21,918 -90	-0.4%	-$4.53K	0.14%	157
2025 Q2	$1.08M	Buy	22,008 +1,274	+6%	+$58.9K	0.15%	150
2025 Q1	$944K	Buy	20,734 +326	+2%	+$15.2K	0.15%	156
2024 Q4	$942K	Buy	20,408 +130	+0.6%	+$5.96K	0.15%	160
2024 Q3	$913K	Hold	20,278	–	–	0.2%	125
2024 Q2	$875K	Buy	20,278 +172	+0.9%	+$7.19K	0.2%	126
2024 Q1	$838K	Buy	+20,106	New	+$815K	0.22%	114

Other funds holding BMAR

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $162M AUM 22.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

RPGK

Retirement Planning Group (Kansas) Leawood, Kansas $3.23B AUM 15.3% 1-Year Est. Return

VBFP

Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

MPCL

My Personal CFO LLC Vancouver, Washington $256M AUM 22.12% 1-Year Est. Return

Consolidated Portfolio Review Corp's BMAR Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Innovator US Equity Buffer ETF March (BMAR) in Q4 2025, closing a stake of 21,918 shares — an estimated $1.13M sold.

Consolidated Portfolio Review Corp first reported a position in BMAR in Q1 2024 and held it in 7 quarters. The position peaked at $1.13M in Q3 2025. 100 funds tracked by Wall St. Rank hold BMAR as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining Innovator US Equity Buffer ETF March position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 21,918 Innovator US Equity Buffer ETF March shares in Q4 2025, an estimated $1.13M.
Consolidated Portfolio Review Corp first reported a position in Innovator US Equity Buffer ETF March in Q1 2024 and held it in 7 quarters.
Consolidated Portfolio Review Corp's Innovator US Equity Buffer ETF March position peaked at $1.13M in Q3 2025.
100 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF March as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.